Brief: Redhill Divests Talicia To Apotex For $18 Million Cash Upfront Plus Milestones
31/08/2026 12:03
BRIEF-Redhill Divests Talicia To Apotex For $18 Million Cash Upfront Plus Milestones Aug 31 (Reuters) - Redhill Biopharma Ltd 2RHy.F:
REDHILL DIVESTS TALICIA® TO APOTEX FOR $18 MILLION CASH UPFRONT PLUS MILESTONES TO FUEL STRATEGIC GROWTH OPPORTUNITIES
REDHILL BIOPHARMA - APOTEX TO RECEIVE REDHILL'S 70% INTEREST IN TALICIA AFTER PRIOR ACQUISITION OF CUMBERLAND'S 30% STAKE
REDHILL BIOPHARMA - APOTEX TO PAY $18 MILLION UPFRONT PLUS UP TO $35 MILLION IN WORLDWIDE NET SALES MILESTONES
Source text: ID:nPreqzlPQa
Further company coverage: [2RHy.F]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Apotex Health
See all newsBrief: Apotex Health Corp. Announces Closing Of $1,250 Million Inaugural Senior Unsecured Notes Offering
Brief: Redhill Divests Talicia To Apotex For $18 Million Cash Upfront Plus Milestones
Brief: Apotex Announces First Quarter 2027 Results
Press Digest: Canada - July 29
Canada Research Roundup: Apotex Health, Manulife Financial, Sun Life Financial